Catalyst Wire Dossier Catalyst Wire Dossier

AGN-232411

· Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGN-232411, covering 2016-07-14 to 2016-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye [Phase 1]

See pricing